Login Register Cart 0
Generic placeholder image

Letters in Organic Chemistry

Editor-in-Chief

ISSN (Print): 1570-1786
ISSN (Online): 1875-6255

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Microwave Irradiated Synthesis of Pyrimidine Containing, Thiazolidin-4- ones: Antimicrobial, Anti-Tuberculosis, Antimalarial and Anti-Protozoa Evaluation

Author(s): Hetal I. Soni*, Navin B. Patel*, Rahul B. Parmar, Manuel J. Chan-Bacab and Gildardo Rivera

Volume 19, Issue 9, 2022

Published on: 10 March, 2022

Page: [731 - 738] Pages: 8

DOI: 10.2174/1570178619666220111124104

Price: $65

Abstract

Aims: This study aims to synthesize thiazolidine-4-one compounds with a pyrimidine nucleus and evaluate against different species of bacteria, fungi, protozoa, and the malaria parasite.

Background: Microwave irradiation was the best method for synthesizing the thiazolidin-4-one ring system. It took only 15 minutes for synthesizing thiazolidin-4-one while the conventional method required 12 hours. The rapid reaction was the main concern of this research.

Objective: Pyrimidine and Thiazolidin-4-one nucleus have broad-spectrum biological activity and when it is introduced with other hetero atoms containing moiety, many types of biological activities have been found; antimicrobial, anti-tuberculosis, anti-protozoa, antimalarial are the main activities. The activity of these compounds inspired us to do extra research on Thiazolidin-4-one fused pyrimidines with different functional groups. The aim of this study is to synthesize a combination of these two ring systems in less time by using a microwave irradiation method and to evaluate new compounds for different bioactivity.

Methods: 2-(4-Chlorophenyl)-3-(4-(substituted phenyl)-6-(substituted aryl) pyrimidin-2-yl) thiazolidin- 4-ones (6A-J) were synthesized by microwave irradiation to save energy and time. The structure of all newly synthesized motifs was characterized by spectral analysis (1H NMR, 13C NMR, IR, spectroscopy) and screened for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pyogenes, antifungal activity against Candida albicans, Aspergillus niger, Aspergillus clavatus, anti-tuberculosis activity against M. tuberculosis H37RV, antimalarial activity against Plasmodium falciparum and anti-protozoa activity against L. mexicana and T. cruzi.

Results: Because of microwave irradiation synthesis, time period is very less for preparing the new compound. Biological response given by compounds 6B, 6C, 6D, 6E, 6G, 6H, and 6J was found excellent.

Conclusion: Good yield with purity of the newly synthesized thiazolidine-4-one compounds obtained in less time by using microwave irradiation. The biological response of some of the compounds of this series was found excellent.

Keywords: Thiazolidin-4-ones, antibacterial, antifungal, anti-tubercular H37RV, antimalarial, anti-protozoa.

« Previous Next »
Graphical Abstract

[1]
Bhawani, S.; Maheshwari, A.; Dak, G.; Sharma, K.; Talesara, G.L. Indian J. Pharm. Sci., 2010, 72(5), 607-612.
[http://dx.doi.org/10.4103/0250-474X.78529] [PMID: 21694993]
[2]
Sadaf, J.; Gilania, K. Nagarajana; Surya, P.; Dixita. Arab. J. Chem., 2012.
[http://dx.doi.org/10.1016/j.arabjc.2012.04.004]
[3]
Barbaros, E.; Keriman, O.S.; Oya, U.T.; Sriram, D.; Perumal, Y.; Ayla, B. Iran. J. Pharm. Res., 2016, 15(4), 783-790.
[http://dx.doi.org/10.22037/IJPR.2016.1911] [PMID: 28243274]
[4]
Renu, D.; Halve, K.; Shinde, P.; Soni, P.K. Int. J. Curr. Pharm. Res., 2015, 7(3), 92-94.
[5]
Soni, H.I.; Patel, N.B. Asian J. Pharm. Clin. Res., 2017, 10, 209-214.
[http://dx.doi.org/10.22159/ajpcr.2017.v10i10.1930]
[6]
Samadhiya, P.; Sharma, R.; Srivastava, S.K.; Srivastava, S.D. Arab. J. Chem., 2014, 7(5), 657-665.
[http://dx.doi.org/10.1016/j.arabjc.2010.11.015]
[7]
Dadlani, V.G.; Somani, R.R.; Tripathi, P.K. Int. J. Pharm. Sci. Res., 2019, 10(5), 2565-2576.
[http://dx.doi.org/10.13040/IJPSR.0975-8232]
[8]
Mistry, B.M. Jauhari. S. Med. Chem. Res., 2013, 22, 647-658.
[http://dx.doi.org/10.1007/s00044-012-0061-7]
[9]
Deshmukh, A.R.; Dhumal, S.T.; Nawale, L.U.; Khedkar, V.M.; Sarkar, D.; Mane, R.A. Synth. Commun., 2019, 49(4), 587-601.
[http://dx.doi.org/10.1080/00397911.2018.1564928]
[10]
Subhedar, D.D.; Shaikh, M.H.; Shingate, B.B.; Nawale, L.; Sarkarb, D.; Khedkar, V.M. MedChemComm, 2016, 7, 1832-1848.
[http://dx.doi.org/10.1039/C6MD00278A]
[11]
Patel, N.B.; Pathan, S.S.; Soni, H.I. Curr. Microw. Chem., 2019, 6, 61-70.
[http://dx.doi.org/10.2174/2213335606666190724093305]
[12]
Kumar, S.; Bhat, H.R.; Kumawat, M.K.; Singh, U.P. New J. Chem., 2013, 37, 581-584.
[http://dx.doi.org/10.1039/c2nj41028a]
[13]
Mital, A.; Murugesan, D.; Kaiser, M.; Yeates, C.; Gilbert, I.H. Eur. J. Med. Chem., 2015, 103, 530-538.
[http://dx.doi.org/10.1016/j.ejmech.2015.08.044] [PMID: 26408453]
[14]
Mahmoodi, N.O.; Zeydi, M.M.; Biazar, E.; Kazeminejad, Z. Phosphorus, Sulfur, and Silicon and the Related Elements, 2017, 192(3), 344-350.
[15]
Živković, M.B.; Matić, I.Z.; Rodić, M.V.; Novaković, I.T.; Krivokuća, A.M.; Sladić, D.M.; Krstić, N.M. Biochem. Mol. Biol., 2017, 174, 72-85.
[http://dx.doi.org/10.1016/j.jsbmb.2017.07.031] [PMID: 28756292]
[16]
Rashid, M.; Husain, A.; Shaharyar, M.; Mishra, R. Eur. J. Med. Chem., 2014, 83, 630-645.
[http://dx.doi.org/10.1016/j.ejmech.2014.06.033] [PMID: 25010935]
[17]
Roa, C.R.; Molina, D.; Cardona, N. Front. Cell. Infect. Microbiol., 2018, 8, 1-8.
[http://dx.doi.org/10.3389/fcimb.2018.00360]
[18]
Singh, T.; Khobragade, D.S. Uni. J. Pharma. Bio. Sci., 2014, 02(01), 13-15.
[19]
Diego, M.; Cossio-Pérez, R.; Cristian, R.R.; Pedraza, L.; Cortes, E.; Hernández, A.; Gómez-Marín, J.E. BMC Genomics, 2018, 19(856), 1-18.
[http://dx.doi.org/10.1186/s12864-018-5223-7] [PMID: 29291715]
[20]
De Carvalho, L.P.; Gomes, A.G.B.; Rocha, M.B.S.; De Oliveira, R.R.; Maria, E.J. J. Dev. Drugs, 2014, 3(2), 1-7.
[http://dx.doi.org/10.4172/2329-6631.1000126]
[21]
De Siqueira, L.R.P.; De Oliveira, B.M.; Oliveira, A.R.; De Moraes Gomes, P.A.T.; De Oliveira Filho, G.B.; De Oliveira Cardoso, M.V.; Perei-ra, V.R.A.; Da Silva Santos, A.C.; Júnior, P.A.S.; Romanha, A.J.; Leite, A.C.L. Chem. Cli. Res, 2019, 2, 1-12.
[http://dx.doi.org/10.15761/FDCCR.1000120]
[22]
Carradori, S.; Secci, D.; Bizzarri, B.; Chimenti, P.; De Monte, C.; Guglielmi, P.; Campestre, C.; Rivanera, D.; Bordón, C.; Jones-Brando, L. J. Enzyme Inhib. Med. Chem., 2017, 32(1), 746-758.
[http://dx.doi.org/10.1080/14756366.2017.1316494] [PMID: 28537532]
[23]
Das Neves, A.M.; Berwaldt, G.A.; Avila, C.T.; Goulart, T.B.; Moreira, B.C.; Ferreira, T.P. J. Enzyme Inhib. Med. Chem., 2020, 35, 31-41.
[http://dx.doi.org/10.1080/14756366.2019.1680659] [PMID: 31645149]
[24]
Suryawanshi, R.; Jadhav, S.; Makwana, N.; Desai, D.; Chaturbhuj, D.; Sonawani, A.; Idicula-Thomas, S. Bioorg. Chem., 2017, 71, 211-218.
[http://dx.doi.org/10.1016/j.bioorg.2017.02.007] [PMID: 28236450]
[25]
Beniwal, M.; Jain, N. Curr. Microw. Chem., 2019, 6, 44-53.
[http://dx.doi.org/10.2174/2213335606666190722144956]
[26]
Singh, I.; Kumar, A. Int. J. Pharm. Sci. Res., 2015, 6, 850-856.
[27]
Patel, N.B. Patel, M.D. Med. Chem. Res., 2017, 26, 1772-1783.
[http://dx.doi.org/10.1007/s00044-017-1837-6]
[28]
Patel, N.B.; Soni, H.I.; Parmar, R.B. Curr. Microw. Chem., 2021, 8, 1-8.
[http://dx.doi.org/10.2174/2213335607999200918155613]
[29]
Rattan, A.; Churchill, B.I. Antimicrobials in laboratory medicine; Livingstone: New Delhi, 2000, pp. 85-108.
[30]
Shweta, S.; Choudhary, P.C.; Intodia, K. Chem. Sci. Trans., 2013, 2, 343-348.
[http://dx.doi.org/10.7598/cst2013.319]
[31]
Patel, N.B.; Soni, H.I.; Parmar, R.B.; Chan-Bacab, M.J.; Rivera, G. Lett. Org. Chem., 2021, 18, 1-8.
[http://dx.doi.org/10.2174/1570178617999201001153113]
[32]
Robert, C. Medical Microbiology, 11th ed; , 1997.
[33]
Anargyros, Astill D.S.; Lim, I.S.P. J. Clin. Microbiol., 1990, 28, 1288-1291.
[http://dx.doi.org/10.1128/JCM.28.6.1288-1291.1990] [PMID: 2116446]
[34]
Shah, R.R.; Mehta, R.D.; Parikh, A.R. J. Indian Chem. Soc., 1985, 62B, 255-257.
[35]
The National Committee for Clinical Laboratory Standard. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts Approved Standard M27A; NCCLS: Wayne, PA, 1997.
[36]
Robert, C. Medical Microbiology, 11th ed; , 1970.
[37]
Rieckmann, K.H.; Campbell, G.H.; Sax, L.J.; Mrema, J.E. Lancet, 1978, 1(8054), 22-23.
[http://dx.doi.org/10.1016/S0140-6736(78)90365-3] [PMID: 74500]
[38]
Desjardins, R.E. In vitro techniques foranti malarial development and evaluation. Springer-Verlag; Peters, W.; Richards, W.H.G., Eds.; Handbook of Experimental Pharmacology Germany , 1984; p. 179-200.
[39]
Trager, W.; Jensen, J.B. Science, 1976, 193(4254), 673-675.
[http://dx.doi.org/10.1126/science.781840] [PMID: 781840]
[40]
Lambros, C.; Vanderberg, J.P. J. Parasitol., 1979, 65(3), 418-420.
[http://dx.doi.org/10.2307/3280287] [PMID: 383936]
[41]
Singh, J. Indian J. Malariol., 1956, 10(2), 117-129.
[PMID: 13366404]
[42]
Panjarathinam, R. Text Book of Medical Parasitology, 2nd ed; Orient Longman Pvt. Ltd.: Chennai, 2007, p. 329.
[http://dx.doi.org/10.22037/IJPR.2016.1911]

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy